The abstract is read at the publisher; the summary is JClub's.
Hypertriglyceridaemia is linked to higher cardiovascular disease risk, with risk mediated by cholesterol in triglyceride-rich remnant particles rather than triglycerides themselves.
- Why it matters: Despite a simple blood test, hypertriglyceridaemia is underdiagnosed and undertreated, and its causes can be primary or secondary, requiring targeted evaluation and management.
- What they did: The International Atherosclerosis Society consensus reviews clinical context and evidence for evaluating, diagnosing, and managing hypertriglyceridaemia, including lifestyle measures and statins when indicated.
- The result: Randomized clinical trial evidence is lacking that triglyceride-targeting drugs reduce cardiovascular events, so elevated triglycerides should prompt optimization of other modifiable cardiovascular risk factors.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.